CMND•benzinga•
Clearmind Medicine Enrolls First Patient In Phase I/IIa Clinical Trial For CMND-100, Proprietary MEAI-Based Oral Drug Candidate Aimed At Treating Alcohol Use Disorder
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 5, 2025 by benzinga